The promise of personalized medicine for hidradenitis suppurativa von Okun, Martin M

Volltext

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa von Kimball, Alexa B, Okun, Martin M, Williams, David A, Gottlieb, Alice B, Papp, Kim A, Zouboulis, Christos C, Armstrong, April W, Kerdel, Francisco, Gold, Michael H, Forman, Seth B, Korman, Neil J, Giamarellos-Bourboulis, Evangelos J, Crowley, Jeffrey J, Lynde, Charles, Reguiai, Ziad, Prens, Errol-Prospero, Alwawi, Eihab, Mostafa, Nael M, Pinsky, Brett, Sundaram, Murali, Gu, Yihua, Carlson, Dawn M, Jemec, Gregor B.E

Volltext

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study von Zouboulis, Christos C., Okun, Martin M., Prens, Errol P., Gniadecki, Robert, Foley, Peter A., Lynde, Charles, Weisman, Jamie, Gu, Yihua, Williams, David A., Jemec, Gregor B.E.

Volltext

Clinical Epidemiology and Management of Hidradenitis Suppurativa von Sayed, Christopher J., Hsiao, Jennifer L., Okun, Martin M.

Volltext

What causes hidradenitis suppurativa ?—15 years after von Zouboulis, Christos C., Benhadou, Farida, Byrd, Angel S., Chandran, Nisha S., Giamarellos‐Bourboulis, Evangelos J., Fabbrocini, Gabriella, Frew, John W., Fujita, Hideki, González‐López, Marcos A., Guillem, Philippe, Gulliver, Wayne P. F., Hamzavi, Iltefat, Hayran, Yildiz, Hórvath, Barbara, Hüe, Sophie, Hunger, Robert E., Ingram, John R., Jemec, Gregor B.E., Ju, Qiang, Kimball, Alexa B., Kirby, Joslyn S., Konstantinou, Maria P., Lowes, Michelle A., MacLeod, Amanda S., Martorell, Antonio, Marzano, Angelo V., Matusiak, Łukasz, Nassif, Aude, Nikiphorou, Elena, Nikolakis, Georgios, Nogueira da Costa, André, Okun, Martin M., Orenstein, Lauren A.V., Pascual, José Carlos, Paus, Ralf, Perin, Benjamin, Prens, Errol P., Röhn, Till A., Szegedi, Andrea, Szepietowski, Jacek C., Tzellos, Thrasyvoulos, Wang, Baoxi, van der Zee, Hessel H.

Volltext

Hidradenitis Suppurativa: Diagnosis and Management in the Emergency Department von Okun, Martin M, Flamm, Avram, Werley, Elizabeth Barrall, Kirby, Joslyn S

Volltext

Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, p... von Kirby, Joslyn S., Okun, Martin M., Alavi, Afsaneh, Bechara, Falk G., Zouboulis, Christos C., Brown, Kurt, Santos, Leandro L., Wang, Annie, Bibeau, Kristen B., Kimball, Alexa B., Porter, Martina L.

Volltext

Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial von Elewski, Boni E., Okun, Martin M., Papp, Kim, Baker, Christopher S., Crowley, Jeffrey J., Guillet, Gérard, Sundaram, Murali, Poulin, Yves, Gu, Yihua, Geng, Ziqian, Williams, David A., Rich, Phoebe A.

Volltext

The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study von Shikiar, Richard, Willian, Mary Kaye, Okun, Martin M, Thompson, Christine S, Revicki, Dennis A

Volltext

Uncovering burden disparity: A comparative analysis of the impact of moderate-to-severe psoriasis and hidradenitis suppurativa von Hamzavi, Iltefat H., Sundaram, Murali, Nicholson, Cynthia, Zivkovic, Marko, Parks-Miller, Angela, Lee, Jianyi, Yi, Jingbo, Gu, Yihua, Okun, Martin M., Ganguli, Arijit, Arikian, Steve R.

Volltext

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial von Menter, Alan, MD, Tyring, Stephen K., MD, PhD, MBA, Gordon, Kenneth, MD, Kimball, Alexa B., MD, MPH, Leonardi, Craig L., MD, Langley, Richard G., MD, Strober, Bruce E., MD, PhD, Kaul, Martin, MD, Gu, Yihua, MS, Okun, Martin, MD, PhD, Papp, Kim, MD

Volltext

Patients’ willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancer von Boeri, Marco, Skelsey, Maral K., Schiro, James A., Dozier, Susan E., Glinert, Robert, Okun, Martin M.

Volltext

Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEE... von Kimball, Alexandra B, Tzellos, Thrasivoulos, Calimlim, Brian M, Teixeira, Henrique D, Geng, Ziqian, Okun, Martin M

Volltext

No Evidence that Variations in Ambient Solar Ultraviolet Radiation and Psoriasis Severity are Associated von Okun, Thomas S. D., Okun, Martin M.

Volltext

Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study von Gordon, Kenneth B., Langley, Richard G., Leonardi, Craig, Toth, Darryl, Menter, M. Alan, Kang, Sewon, Heffernan, Michael, Miller, Bruce, Hamlin, Regina, Lim, Liberata, Zhong, Jianhua, Hoffman, Rebecca, Okun, Martin M.

Volltext

Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study von Asahina, Akihiko, Ohtsuki, Mamitaro, Etoh, Takafumi, Gu, Yihua, Okun, Martin M., Teixeira, Henrique D., Yamaguchi, Yuji, Nakagawa, Hidemi

Volltext

Validation of the Physician's Global Assessment of Fingernail Psoriasis by Rheumatologists Treating Psoriatic Arthritis von Hudgens, Stacie, Gugiu, Cristian, Guobyte, Aiste, Soliman, Ahmed M, Fitzgerald, Kristina A, Barcomb, Lisa M, Eldred, Ann K, Okun, Martin M

Volltext

Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study von Strober, Bruce E., MD, PhD, Poulin, Yves, MD, Kerdel, Francisco A., MD, Langley, Richard G., MD, Gu, Yihua, MS, Gupta, Shiraz R., PharmD, MPH, Okun, Martin M., MD, PhD, Papp, Kim A., MD, PhD

Volltext

Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement von Mastacouris, Nicole, Tannenbaum, Rachel, Strunk, Andrew, Koptyev, Jonathan, Aarts, Pim, Alhusayen, Raed, Bechara, Falk G, Benhadou, Farida, Bettoli, Vincenzo, Brassard, Alain, Brown, Debra, Choon, Siew Eng, Coutts, Patricia, da Silva, Dimitri Luz Felipe, Daveluy, Steven, Dellavalle, Robert P, del Marmol, Veronique, Emtestam, Lennart, Gebauer, Kurt, George, Ralph, Giamarellos-Bourboulis, Evangelos J, Goldfarb, Noah, Hamzavi, Iltefat, Hazen, Paul G, Horváth, Barbara, Hsiao, Jennifer, Ingram, John R, Jemec, Gregor B. E, Kirby, Joslyn S, Lowes, Michelle A, Marzano, Angelo V, Matusiak, Lukasz, Naik, Haley B, Okun, Martin M, Oon, Hazel H, Orenstein, Lauren A. V, Paek, So Yeon, Pascual, José C, Fernandez-Peñas, Pablo, Resnik, Barry I, Sayed, Christopher J, Thorlacius, Linnea, van der Zee, Hessel H, van Straalen, Kelsey R, Garg, Amit

Volltext

Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials von Gordon, Kenneth B., Betts, Keith A., Sundaram, Murali, Signorovitch, James E., Li, Junlong, Xie, Meng, Wu, Eric Q., Okun, Martin M.

Volltext